Evercore ISI raised the firm’s price target on Procter & Gamble to $177 from $175 and keeps an Outperform rating on the shares. While “understandably” the focus in the earnings call was on the drivers of sales slowing to 3%, comps considered, this 3% rate already marks a rebound versus prior Q2 on a two-year stack and three-year run rate basis, says the analyst, who adds that calendar 2025 Street expectations “strike us as conservative.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble’s Bold Buyback: Balancing Share Repurchases with Financial Health Risks
- PG Earnings: Procter & Gamble’s Q3 Revenues Disappoint
- Procter & Gamble: Uncovering Hidden Gems for Market Growth
- Procter & Gamble expects oil, diesel, pulp costs to impact Q4
- Unusually active option classes on open April 19th